Holen Sie sich die Stockscreener-App
130.50
1.12%
-1.48
Vorhandelsmarkt:
129.80
-0.70
-0.54%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ILMN?
Forum
Prognose
Aktiensplit
Illumina Inc Aktie (ILMN) Neueste Nachrichten
DNA Extraction, Isolation and Purification Market: Key Players - openPR.com
Gene Expression Analysis Market Set for Robust Growth to USD - openPR.com
Illumina Inc. (ILMN) – Pediatric Genomics Collaboration Bolsters Long-Term Growth Narrative Amid Mixed Historical ReturnsFast Rising Picks - Xã Châu Thành
Illumina Inc. (ILMN) Launches DRAGEN v4.5 Bioinformatics Suite, Expanding Addressable Market in Genomic Research and Clinical OncologyPost Announcement - Xã Thanh Hà
CSR News Feed | Explore the latest corporate social responsibility news from Illumina - Illumina
South America Next Generation Sequencing eDNA Biomonitoring - openPR.com
Metagenomics Market Key Companies AnalysisMerck KGaA, Thermo - openPR.com
Pharmacogenomics Market Leading Companies | F. Hoffmann-la - openPR.com
Metafoodx to Showcase Award-Winning AI Kitchen Intelligence Platform at the 2026 National Restaurant Association Show - GlobeNewswire Inc.
Illumina Inc. stock underperforms Monday when compared to competitors - MarketWatch
Tsinghua University brings hands-on multiomics training to young scientists - Illumina
UPS, Netflix, BlackRock And A Health Care Stock On CNBC's 'Final Trades'BlackRock (NYSE:BLK), Illumina - Benzinga
Illumina, Inc. Common Stock Ex-distribution When-Issued (ILMNV) - Minichart
Behavioral Patterns of ILMN and Institutional Flows - Stock Traders Daily
Illumina, Inc. $ILMN Shares Acquired by Cwm LLC - MarketBeat
Illumina Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Illumina (ILMN), Labcorp (LH) expand precision oncology NGS collaboration - MSN
ILMN Stock Price, Quote & Chart | ILLUMINA INC (NASDAQ:ILMN) - ChartMill
DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows - PR Newswire
Robeco Institutional Asset Management B.V. Trims Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Illumina, Inc. (NASDAQ:ILMN) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Illumina Inc. stock (US4523271090): Why does its genomics dominance matter more now for U.S. investo - AD HOC NEWS
Illumina’s Pediatric Genomics Push Tests Long Term Growth Narrative - Yahoo Finance
Illumina partners with D3b on pediatric genomic data initiative By Investing.com - Investing.com Canada
How Investors Are Reacting To Illumina (ILMN) Board Turnover And Expanded Labcorp Precision Oncology Partnership - simplywall.st
Illumina partners with D3b on pediatric genomic data initiative - Investing.com
Illumina Partners with D3b to Advance Pediatric Cancer Research - Intellectia AI
100,000 child genomes power rare disease and cancer research - Stock Titan
Third View Private Wealth LLC Buys Shares of Illumina, Inc. - National Today
Third View Private Wealth LLC Buys Shares of 16,207 Illumina, Inc. $ILMN - MarketBeat
Massachusetts Financial Services Co. MA Invests $73.53 Million in Illumina, Inc. $ILMN - MarketBeat
Hardman Johnston Trims Illumina Stake - National Today
Illumina, Inc. $ILMN Shares Sold by Hardman Johnston Global Advisors LLC - MarketBeat
Illumina, Inc. $ILMN Holdings Decreased by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Baillie Gifford & Co. Reduces Position in Illumina, Inc. $ILMN - MarketBeat
ILMN Q4 2025 Earnings: Illumina Inc. beats EPS views, no revenue reportedCommunity Pattern Alerts - Xã Thanh Hà
Bioinformatics Market 2026- 2033 Overview: Share, Size, Value, - openPR.com
Illumina (ILMN), Labcorp (LH) Expand Precision Oncology NGS Collaboration - Insider Monkey
Epigenetics Market to Grow from US$ 2.06 Billion in 2024 to US$ - openPR.com
Illumina Inc. stock (US4523271090): Is its genomics leadership strong enough for long-term U.S. inve - AD HOC NEWS
Is It Time To Reassess Illumina (ILMN) After Its 61.7% One Year Share Price Rebound - Yahoo Finance
Is Illumina Stock Undervalued at $121? - TIKR.com
Illumina Inc stock (US4523271090): Is its genomics dominance strong enough to unlock new upside? - AD HOC NEWS
Illumina Inc. stock outperforms competitors despite losses on the day - MarketWatch
Will Illumina (ILMN) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Global Next-Generation Sequencing (NGS) Market to Double in Size by 2030 - GlobeNewswire Inc.
Illumina Stock: Competitive Threats Priced In (NASDAQ:ILMN) - Seeking Alpha
Illumina Inc (ILMN) Stock Down 3.4% -- Now Undervalued? GF Score: 83/100 - GuruFocus
Informatics advances reveal the TruPath™ Genome towards comprehensive genomic insights - Illumina
Illumina Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Illumina to Announce First Quarter 2026 Financial Results on Thursday, April 30, 2026 - marketscreener.com
[ARS] ILLUMINA, INC. SEC Filing - Stock Titan
3 Reasons to Avoid ILMN and 1 Stock to Buy Instead - Yahoo Finance
Illumina Inc. stock rises Wednesday, still underperforms market - MarketWatch
(ILMN) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Illumina, Inc. (ILMN) Stock Forecasts - Yahoo Finance
New Zealand gains genomic testing independence - Illumina
Illumina, Inc. $ILMN Shares Sold by Aberdeen Group plc - MarketBeat
Illumina rejigs board of directors - Medical Buyer
Illumina, Inc. (ILMN) Stock Analysis: Navigating The Path Ahead With 6.85% Potential Upside - DirectorsTalk Interviews
Cathie Wood's Called It Years Ago – Illumina Is the Must-Own Personalized Biotech Stock - Money Morning
Illumina, Inc. (ILMN) stock price, news, quote and history - Yahoo Finance Singapore
0.29%
1.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):